Literature DB >> 12403354

Evaluating function of transmembrane protein tyrosine phosphatase CD148 in lymphocyte biology.

Thomas R Harrod1, Louis B Justement.   

Abstract

The transmembrane protein tyrosine phosphatase CD148 is expressed on numerous cell types, including most cells of the hematopoietic lineage. CD148 has been shown to regulate density-dependent inhibition of cell growth as well as cellular differentiation in nonhematopoietic cells and has been shown to regulate signal transduction processes in several nonlymphoid hematopoietic cell types. Analysis of CD148 expression on lymphoid cells has demonstrated that CD148 is expressed at low levels on T cells and that it is upregulated in response to activation. Several groups have observed that CD148 negatively regulates T cell activation in response to crosslinking of the T cell antigen receptor, suggesting that it may play a role in feedback inhibition of the T cell immune response. In the B cell compartment, CD 148 expression appears to be restricted to the memory subpopulation, raising the possibility that it serves a unique function in these cells, which has yet to be determined. Recent studies have shown that CD148 interacts with the PDZ domain-containing protein syntenin, raising the possibility that its function or its localization with substrates in T and B cells may be controlled through this or a related interaction with another PDZ domain protein.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12403354     DOI: 10.1385/ir:26:1-3:153

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  29 in total

1.  Rat protein tyrosine phosphatase eta suppresses the neoplastic phenotype of retrovirally transformed thyroid cells through the stabilization of p27(Kip1).

Authors:  F Trapasso; R Iuliano; A Boccia; A Stella; R Visconti; P Bruni; G Baldassarre; M Santoro; G Viglietto; A Fusco
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

2.  Expression of the membrane protein tyrosine phosphatase CD148 in human tissues.

Authors:  F Autschbach; E Palou; G Mechtersheimer; C Rohr; F Pirotto; N Gassler; H F Otto; B Schraven; A Gaya
Journal:  Tissue Antigens       Date:  1999-11

3.  Site-selective dephosphorylation of the platelet-derived growth factor beta-receptor by the receptor-like protein-tyrosine phosphatase DEP-1.

Authors:  M Kovalenko; K Denner; J Sandström; C Persson; S Gross; E Jandt; R Vilella; F Böhmer; A Ostman
Journal:  J Biol Chem       Date:  2000-05-26       Impact factor: 5.157

4.  CD148: a receptor-type protein tyrosine phosphatase involved in the regulation of human T cell activation.

Authors:  S G Tangye; J H Phillips; L L Lanier; J E de Vries; G Aversa
Journal:  J Immunol       Date:  1998-10-01       Impact factor: 5.422

5.  CD148, a membrane protein tyrosine phosphatase, is able to induce tyrosine phosphorylation on human lymphocytes.

Authors:  E Palou; M A de la Fuente-García; J M Nicolás; C Vilardell; J Vives; A Gayá
Journal:  Immunol Lett       Date:  1997-06-01       Impact factor: 3.685

6.  Protein tyrosine phosphatase CD148-mediated inhibition of T-cell receptor signal transduction is associated with reduced LAT and phospholipase Cgamma1 phosphorylation.

Authors:  J E Baker; R Majeti; S G Tangye; A Weiss
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

7.  Expression on human eosinophils of CD148: a membrane tyrosine phosphatase. Implications in the effector function of eosinophils.

Authors:  V del Pozo; F Pirotto; B Cárdaba; I Cortegano; S Gallardo; M Rojo; I Arrieta; E Aceituno; P Palomino; A Gaya; C Lahoz
Journal:  J Leukoc Biol       Date:  2000-07       Impact factor: 4.962

8.  Murine DEP-1, a receptor protein tyrosine phosphatase, is expressed in macrophages and is regulated by CSF-1 and LPS.

Authors:  J M Osborne; N den Elzen; A M Lichanska; E O Costelloe; T Yamada; A I Cassady; D A Hume
Journal:  J Leukoc Biol       Date:  1998-11       Impact factor: 4.962

9.  Orthovanadate both mimics and antagonizes the transforming growth factor beta action on normal rat kidney cells.

Authors:  G Rijksen; M C Völler; E J Van Zoelen
Journal:  J Cell Physiol       Date:  1993-02       Impact factor: 6.384

10.  The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells.

Authors:  M M Keane; G A Lowrey; S A Ettenberg; M A Dayton; S Lipkowitz
Journal:  Cancer Res       Date:  1996-09-15       Impact factor: 12.701

View more
  5 in total

Review 1.  SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels.

Authors:  Ulrike Lorenz
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

2.  CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.

Authors:  Konstantin Tsoyi; Xiaoliang Liang; Giulia De Rossi; Stefan W Ryter; Kevin Xiong; Sarah G Chu; Xiaoli Liu; Bonna Ith; Lindsay J Celada; Freddy Romero; Matthew J Robertson; Anthony J Esposito; Sergio Poli; Souheil El-Chemaly; Mark A Perrella; YuanYuan Shi; James Whiteford; Ivan O Rosas
Journal:  Am J Respir Crit Care Med       Date:  2021-08-01       Impact factor: 30.528

Review 3.  MicroRNAs, Long Non-Coding RNAs, and Circular RNAs: Potential Biomarkers and Therapeutic Targets in Pheochromocytoma/Paraganglioma.

Authors:  Peter Istvan Turai; Gábor Nyírő; Henriett Butz; Attila Patócs; Peter Igaz
Journal:  Cancers (Basel)       Date:  2021-03-26       Impact factor: 6.639

Review 4.  Targeting tumor invasion: the roles of MDA-9/Syntenin.

Authors:  Timothy P Kegelman; Swadesh K Das; Luni Emdad; Bin Hu; Mitchell E Menezes; Praveen Bhoopathi; Xiang-Yang Wang; Maurizio Pellecchia; Devanand Sarkar; Paul B Fisher
Journal:  Expert Opin Ther Targets       Date:  2014-09-15       Impact factor: 6.902

5.  Comprehensive Analysis of Aberrantly Expressed Competitive Endogenous RNA Network and Identification of Prognostic Biomarkers in Pheochromocytoma and Paraganglioma.

Authors:  Zijun Wang; Yijian Li; Yanjun Zhong; Yinhuai Wang; Mou Peng
Journal:  Onco Targets Ther       Date:  2020-11-06       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.